TrademarkDir
HEPAZYME
DEAD

Serial Number

75484647

Owner

Ribozyme Pharmaceuticals Incorporated

Attorney

Edward M. Jordan

Filing Date

May 13, 1998

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

HEPAZYME Trademark

Serial Number: 75484647

HEPAZYME is a trademark filed by Ribozyme Pharmaceuticals Incorporated on May 13, 1998. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Ribozyme Pharmaceuticals Incorporated (70 trademarks)

2950 Wilderness Place
Boulder, CO 80301

Entity Type: 03

Trademark Details

Filing Date

May 13, 1998

Registration Date

Not Registered

Published for Opposition

August 2, 2005

Goods & Services

Medicinal and biological product research, development and testing

Filing History

UNDELIVERABLE MAIL - NO ACTION TAKEN
Jul 13, 2006 UNDN
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jun 26, 2006 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 26, 2006 ABN6
UNDELIVERABLE MAIL - NO ACTION TAKEN
Dec 2, 2005 UNDN
PAPER RECEIVED
Nov 22, 2005 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 25, 2005 NOAM
UNDELIVERABLE MAIL - NO ACTION TAKEN
Aug 2, 2005 UNDN
PAPER RECEIVED
Aug 2, 2005 MAIL
PUBLISHED FOR OPPOSITION
Aug 2, 2005 PUBO
NOTICE OF PUBLICATION
Jul 13, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 16, 2005 PREV
ASSIGNED TO LIE
Feb 16, 2005 ALIE
ASSIGNED TO LIE
Feb 4, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 31, 2005 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 6, 2004 RCCK
CASE FILE IN TICRS
Mar 18, 2004 CFIT
ASSIGNED TO EXAMINER
Jul 23, 2002 DOCK
LETTER OF SUSPENSION MAILED
Jan 24, 2002 CNSL
ASSIGNED TO EXAMINER
Jan 22, 2002 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2001 CRFA
ASSIGNED TO EXAMINER
Apr 7, 2001 DOCK
LETTER OF SUSPENSION MAILED
Jan 19, 1999 CNSL
ASSIGNED TO EXAMINER
Jan 15, 1999 DOCK
ASSIGNED TO EXAMINER
Dec 18, 1998 DOCK
ASSIGNED TO EXAMINER
Dec 14, 1998 DOCK

Related Trademarks

More from this Owner

SINATX

SINATX

SINATX

SINATX

SIRNATX

SIRNATX

SIRNATX

SIRNATX

SIRNA THERAPEUTICS

SIRNA THERAPEUTICS

SIGENE

SIGENE